SCHEMBL5378633

SCHEMBL5378633

O=C(O)Nc1ccc([C@@H]2[C@H]3COC(=O)[C@H]32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.37
FPR2 P25090 1/20 0.36
KDM1A O60341 8/20 0.33
MAOA P21397 8/20 0.33
MAOB P27338 8/20 0.33
RCOR1 Q9UKL0 4/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 1/20 0.33
MITF O75030 1/20 0.33
KLF5 Q13887 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KDM1B Q8NB78 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373981 0.78 NPC1 (0.36) MAOBNPC1RAB9AMEN1KMT2A
SCHEMBL7402852 0.77 TSHR (0.40) RAB9AGAAMAPT
SCHEMBL15420541 0.70 HDAC3 (0.42) KDM1AMAOAMAOBRCOR1NPC1
SCHEMBL10778839 0.67 SMN1; SMN2 (0.52) MAOAMAOBNPC1RAB9AKMT2A
Hydrochloric Acid SCHEMBL11405284 0.65 SMN1; SMN2 (0.50) MAOAMAOBNPC1RAB9AKMT2A
SCHEMBL27091789 0.65 HDAC8 (0.55) NPC1RAB9AMITFKLF5ALDH1A1
SCHEMBL21224957 0.65 ESR2 (0.58) NPC1RAB9AMITFKLF5ALDH1A1
SCHEMBL15921072 0.65 HSD17B10 (0.40)
SCHEMBL23728280 0.64 HDAC3 (0.42) KDM1AMAOAMAOBRCOR1NPC1
SCHEMBL17287961 0.64 KDM1A (0.69) KDM1AMAOAMAOBRCOR1KDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 PKM 3472/4885FPR2 885/4885KDM1A 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.